Feasibility analysis of ACTH adenoma model in USP8-/- mice

Jia Li1, Na Wu2, Dimin Zhu3

  • 1Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China. lijialika@163.com.

Endokrynologia Polska
|March 14, 2023
PubMed
Abstract

Insights

USP8 gene mutations are linked to ACTH-secreting pituitary tumors. USP8 knockout mice exhibit increased pituitary ACTH, suggesting their potential as an animal model for ACTH adenoma.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • Somatic mutations in the USP8 gene are found in 35%-60% of adrenocorticotropic hormone (ACTH)-secreting pituitary tumors.
  • USP8 mutations disrupt epidermal growth factor receptor (EGFR) deubiquitination, leading to aberrant EGFR signaling, excessive ACTH production, and cell growth.
  • USP8 is identified as a key gene associated with Cushing's disease.

Purpose of the Study:

  • To investigate the role of USP8 in ACTH adenoma development.
  • To establish and characterize USP8 mutant mouse models for studying pituitary tumor formation.

Main Methods:

  • Generation and analysis of USP8 mutant mouse models (USP8+/- and USP8-/-).
  • Phenotypic analysis, biochemical index detection, and pituitary/adrenal tissue examination (HE staining, immunohistochemistry).
  • Comparison of mutant mice with wild-type counterparts.

Main Results:

  • USP8 mutant mice (USP8+/- and USP8-/-) showed significantly increased pituitary ACTH expression compared to wild-type mice (p < 0.05).
  • USP8-/- mice exhibited higher blood glucose and heart rates than wild-type and USP8+/- mice.
  • No significant pathological changes were observed in pituitary and adrenal tissues across the groups.

Conclusions:

  • USP8 knockout mice demonstrate potential as a valuable animal model for studying ACTH adenoma.
  • These findings highlight the critical role of USP8 in the pathogenesis of ACTH-secreting pituitary tumors.

Related Concept Videos